A Phase 2/3 interventional study of Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine in Pain Management After Functional Endoscopic Sinuscopy, sponsored by South Egypt Cancer Institute. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-04-29.
Sponsored by South Egypt Cancer Institute · Phase 2/3, Interventional, and Supportive care
Improving postoperative analgesia after functional endoscopic surgery: Sphenopalatine ganglion block versus soaked nasal packing using bupivacaine and dexmedetomidine
Exclusion Criteria:
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Drug: Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Drug: Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
Sphenopalatine ganglion block (SPGB) with Bupivacaine and Dexmedetomidine
effectiveness of SPGB with bupivacaine and dexmedetomidine for postoperative analgesia
Numeric rating scale for pain will be assessed and recorded within the first 24 hours where 1 means the worst pain and 10 means no pain. Total rescue analgesia in 24 H when Numeric rating scale ≥ 4 was recorded and the first time when it was given will be recorded.
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
South Egypt Cancer Institute